Platform Delivery Technology: working double time for transdermal drugs and...
XPhyto Therapeutics outlines the latest developments concerning its generic transdermal patch to support sufferers of Parkinson’s disease and discusses the commercialisation of its innovative...
The importance of testing for Trichomoniasis
Here, Sekisui Diagnostics, the innovative company behind the OSOM® Trichomonas test, explore the common sexually transmitted infection, trichomoniasis, outlining key symptoms, complications, treatments and...
Defence Therapeutics’ technology optimises cancer vaccine efficacy
Biotechnology experts Defence Therapeutics are leading the fight against cancer and infectious diseases. Discover how their revolutionary drug enhancer platform is elevating cancer vaccine...
Are alcohol hand sanitisers effective against COVID-19 and PATHOGENS?
Following the sharp uptake in hand sanitiser products during the COVID-19 pandemic, Professor Nigel Silman, Visiting Chair in Infectious Disease at the University of...
The detergent-disinfectant wipe that reduces MRSA acquisitions by 55%
From infection prevention specialists GAMA Healthcare, Clinell Universal Wipes reduced MRSA acquisitions in a large teaching hospital in the UK.
In 2021, new guidelines were...
Enhancing the efficacy of cancer vaccines and antibody drug conjugates
In its quest to optimise treatment for cancer and infectious diseases, Defence Therapeutics illustrates how its groundbreaking Accum technology elevates the performance of vaccines...
Low-intensity Vibration Therapy: Combatting an osteoporosis epidemic
MyBones outlines the challenges to global bone health revealed by SCOPE 2021, and how Low-intensity Vibration therapy offers an innovative way to prevent and...
Hand hygiene compliance: Manual observation is no longer acceptable
Driving improvement of the most important infection prevention practice – hand hygiene compliance.
Well before COVID-19, Healthcare Acquired Infections (HAIs) were leading to mortality rates...
Combatting antimicrobial resistance with automated and fast PCR testing
Dr Beryl Oppenheim, Senior Director, Medical Affairs at Cepheid, an industry-leading company in molecular diagnostics, provides insights into how their cutting-edge technology can alleviate...
Mitigating contamination threats with microbial analysis and water testing
Nova Biologicals, a leading microbiological testing service, outlines how microscopic contaminants can be mitigated and contained through microbial analysis methods such as water testing.
Microscopic...
Defence Therapeutics: Accelerating the fight against cancer and infectious diseases
Defence Therapeutics outlines how it is actively looking to continue the development of its product pipeline in partnership with large pharmaceutical companies.
Defence Therapeutics, a...
XPhyto: Taking biosensors to the next level
2022 could mark a breakout year for XPhyto Therapeutics Corp. as they look at taking their rapid detection of bacterial and infectious disease technology...
Enhancing access to healthcare with point-of-care diagnostics technology
Experts in the field of blood count testing diagnostics – PixCell Medical – illustrate how their cutting-edge technology can optimise access to healthcare in...
Sysmex: Alleviating the burden of antimicrobial resistance (AMR)
The developing threat of antimicrobial resistance on global health is proving to be challenging. Sysmex Europe outlines the burden and prevention of antimicrobial resistance...
Transforming diagnostic testing for biomarkers with Egoo.health platform
Egoo.Health Platform is transforming testing for biomarkers with their diagnostics device, which delivers everyone from ordinary people to healthcare professionals, the opportunity to monitor...
One1Star Solutions revolutionising most Advanced TAED globally
One1Star Solutions introduces its groundbreaking Tetraacetylethylenediamine (TAED), an innovative solution to cleaning and disinfection needs for a vast range of sectors.
One1Star Solutions has patented...
LumiraDx: Fighting antimicrobial resistance with innovative POC testing
Antimicrobial resistance (AMR) is ever-evolving and perhaps the most dangerous global health threat of modern times, an issue that will require cutting-edge innovation to...
Big Boost for NervGen’s Phase II Clinical Trials
In a groundbreaking development for paralysed people, the revolutionary NVG-291 treatment for spinal cord injury is set to undergo Phase II clinical trials in...
The challenges and opportunities associated with phage therapy
Dr Zemphira Alavidze, a medical microbiologist at Phage Therapy Center, explains the benefits and challenges associated with phage therapy.
Phage Therapy Center was founded in...
Amarin: Changing the landscape of residual cardiovascular disease risk
World-leading pioneers of the pharmaceutical industry, Amarin Corporation, comprehensively explore the ever-evolving landscape of cardiovascular disease, analysing the current challenges facing mitigating the impacts...
